Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMAAM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,166
Award facts
- Contract value 100% obligated
- $32,165.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,165.66 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 14, 2025, with an ultimate completion date of October 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply agreement running through December 2026 that enables AmerisourceBergen to distribute a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical supply requirements through open competition. Under the DLA Troop Support Medical prime vendor vehicle, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key player in the Department of Defense's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB26FMAAM?
SPE2DB26FMAAM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FMAAM worth?
The government has obligated $32,166 on SPE2DB26FMAAM.
Is contract SPE2DB26FMAAM an order under another contract?
Yes. SPE2DB26FMAAM is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMAAM competed?
The extent of competition for SPE2DB26FMAAM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award